BIOFILCHEM

BIOFIL CHEMICALS & PHARMACEUTICALS

Small Cap BSE: 524396 NSE: BIOFILCHEM
₹48.00
0.5 (1.05%)
As on 30 September, 2022 | 03:03

Biofil Chemicals & Pharmaceuticals Share Price

Biofil Chemicals & Pharmaceuticals Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in BIOFIL CHEMICALS & PHARMACEUTICALS

Start SIP

Biofil Chemicals & Pharmaceuticals Share Returns

  • Over 1 Month -7.08%
  • Over 3 Month -7.26%
  • Over 6 Month -18.68%
  • Over 1 Year -24.03%

Biofil Chemicals & Pharmaceuticals Key Statistics

P/E Ratio 106.9
PEG Ratio -2.7
Market Cap Cr 78
Price to Book Ratio 4.6
EPS 0.4
Dividend 0
Relative Strength Index 30.02
Money Flow Index 11.06
MACD Signal -0.67
Average True Range 2.1

Biofil Chemicals & Pharmaceuticals Investment Rating

  • Master Rating:
  • Biofil Chemicals & Pharmaceuticals has an operating revenue of Rs. 29.32 Cr. on a trailing 12-month basis. An annual revenue de-growth of -38% needs improvement, Pre-tax margin of 5% is okay, ROE of 4% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 51 which is a POOR score indicating inconsistency in earnings, a RS Rating of 14 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 151 indicates it belongs to a poor industry group of Medical-Ethical Drugs and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Biofil Chemicals & Pharmaceuticals Financials
IndicatorJun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 122214514
Operating Expenses Qtr Cr 122113514
Operating Profit Qtr Cr 000000
Depreciation Qtr Cr 000000
Interest Qtr Cr 000000
Tax Qtr Cr 000001
Net Profit Qtr Cr 000000

Biofil Chemicals & Pharmaceuticals Technicals

EMA & SMA

Current Price
47.9
0.4 (0.84%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 50.59
  • 50 Day
  • 51.96
  • 100 Day
  • 54.39
  • 200 Day
  • 60.26
  • 20 Day
  • 51.24
  • 50 Day
  • 52.13
  • 100 Day
  • 53.31
  • 200 Day
  • 60.32

Biofil Chemicals & Pharmaceuticals Resistance and Support

PIVOT
₹47.72
Resistance
First Resistance 48.44
Second Resistance 49.37
Third Resistance 50.09
RSI 30.02
MFI 11.06
MACD Single Line -0.67
MACD -1.12
Support
First Resistance 46.79
Second Resistance 46.07
Third Resistance 45.14

Biofil Chemicals & Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 14,353 798,744 55.65
Week 18,619 1,142,648 61.37
1 Month 21,581 1,381,403 64.01
6 Month 41,454 2,173,025 52.42

Biofil Chemicals & Pharmaceuticals Result Highlights

Biofil Chemicals & Pharmaceuticals Synopsis

NSE-Medical-Ethical Drugs

Biofil Chemicals belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 35.75 Cr. and Equity Capital is Rs. 16.27 Cr. for the Year ended 31/03/2021. Biofil Chemicals & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 04/01/1985 and has its registered office in the State of Madhya Pradesh, India. Company’s Corporate Identification Number(CIN) is L24233MP1985PLC002709 and registration number is 002709.
Market Cap 78
Sales 29
Shares in Float 0.86
No of funds 5
Yield
Book Value 4.63
U/D Vol ratio 0.9
LTDebt / Equity
Alpha -0.03
Beta 1.2

Biofil Chemicals & Pharmaceuticals

Owner NameJun-22Mar-22Dec-21Sep-21
Promoters 46.82%46.82%46.82%
Financial Institutions/ Banks 0.08%0.08%0.08%
Individual Investors 37.84%37.97%37.96%
Others 15.26%15.13%15.14%

Biofil Chemicals & Pharmaceuticals Management

Name Designation
Mr. Ramesh Shah Managing Director
Mr. Ketan Shah Whole Time Director
Mr. Romil Shah Non Executive Director
Mrs. Shaila Jain Independent Director
Mr. Satish Beohar Independent Director
Mr. Ashok Kumar Ramawat Independent Director

Biofil Chemicals & Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Biofil Chemicals & Pharmaceuticals Corporate Action

Date Purpose Remarks
2022-08-09 Quarterly Results
2022-05-30 Audited Results
2022-02-14 Quarterly Results
2021-11-12 Quarterly Results
2021-08-13 Quarterly Results & A.G.M.

Biofil Chemicals & Pharmaceuticals FAQs

What is Share Price of Biofil Chemicals & Pharmaceuticals ?

Biofil Chemicals & Pharmaceuticals share price is ₹48 As on 30 September, 2022 | 02:49

What is the Market Cap of Biofil Chemicals & Pharmaceuticals ?

The Market Cap of Biofil Chemicals & Pharmaceuticals is ₹78.1 Cr As on 30 September, 2022 | 02:49

What is the P/E ratio of Biofil Chemicals & Pharmaceuticals ?

The P/E ratio of Biofil Chemicals & Pharmaceuticals is 106.9 As on 30 September, 2022 | 02:49

What is the PB ratio of Biofil Chemicals & Pharmaceuticals ?

The PB ratio of Biofil Chemicals & Pharmaceuticals is 4.6 As on 30 September, 2022 | 02:49

Q1FY23